These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4232163)

  • 21. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes of insulin-induced hypoglycemia in rats pretreated with reserpine or with epsilon-aminocaproic acid (EAC) or with epsilon-acetamido-caproic acid (EACA)].
    Agliati G; Conti F; Pelosi G
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1824-7. PubMed ID: 5733081
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinolysis.
    Fearnley GR
    Adv Drug Res; 1973; 7():107-63. PubMed ID: 4280240
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the fibrinolytic activity of the plasma of thrombopenic patients and the effect of corticoids and epsilon-aminocaproic acid].
    Pileggi JE
    Sangre (Barc); 1967; 12(4):375-82. PubMed ID: 5614843
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of epsilon-amino-caproic acid (EAC) on specific skin tests of the immediate type and on local passive transport of sensitivity, using the Prausnitz-Küstner method].
    Noferi A; Volpari AL; Mancuso A
    Folia Allergol (Roma); 1969; 16(2):169-72. PubMed ID: 5794520
    [No Abstract]   [Full Text] [Related]  

  • 29. Measurement of the inhibitor of plasminogen activation in the euglobulin test.
    Januszko T; Buluk K; Uszyńska-Folejewska R; Uszyński M
    Pol Med J; 1966; 5(4):914-9. PubMed ID: 5964912
    [No Abstract]   [Full Text] [Related]  

  • 30. [Origin and physiological significance of "activated" plasminogen and plasmin for the mobilization of the anticoagulation system].
    Kudrjaschow BA; Liapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(3):313-21. PubMed ID: 4123095
    [No Abstract]   [Full Text] [Related]  

  • 31. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered?
    Nielsen VG; Cankovic L; Steenwyk BL
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):35-9. PubMed ID: 17179824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Action of epsilon-aminocaproic acid and of parotid inhibitor on the fibrinolysis activation due to nicotinic acid derivatives and to heparin-like substances.
    Gibelli A; Turazza G; Giarola P; De Nicola P
    Farmaco Sci; 1966 Apr; 21(4):301-9. PubMed ID: 4160699
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the role of basophils and mast cells in fibrinolysis and allergy. 3. Effect of an allergic immediate reaction without and with pretreatment with epsilon-aminocaproic acid or p-amino-benzoic acid on number and degranulation of basophils].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(1):1-16. PubMed ID: 4173663
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of thrombin, plasmin and plasminogen activation by amidino compounds.
    Geratz JD
    Thromb Diath Haemorrh; 1970 Jun; 23(3):486-99. PubMed ID: 4247029
    [No Abstract]   [Full Text] [Related]  

  • 35. [Feeding trials with epsilon-aminocaproic acid in animal experiments and its effect on the vascular system].
    Kommerell B; Fritsch H; Gilsdorf U
    Z Gesamte Exp Med Einschl Exp Chir; 1966; 140(3):191-201. PubMed ID: 5992167
    [No Abstract]   [Full Text] [Related]  

  • 36. [Usefulness of EACA in conditions of fibrinolysis activation in obstetrics and gynecology].
    Trebicka-Kwiatkowska B; Radomański T; Ostasz T
    Wiad Lek; 1973 Feb; 26(4):297-303. PubMed ID: 4688816
    [No Abstract]   [Full Text] [Related]  

  • 37. [The origin and physiological importance of activated plasminogen and plasmin in excitation of the anticoagulative system].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1973; 19(2):136-40. PubMed ID: 4267634
    [No Abstract]   [Full Text] [Related]  

  • 38. On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):67-85. PubMed ID: 4257701
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of combined administration of EACA and heparin on thrombus weight and fibrinolysis. An experimental study.
    Komatsu K; Hayakawa D; Suzuki K; Tomita S; Fukushima Y
    Bull Tokyo Med Dent Univ; 1973 Mar; 20(1):93-104. PubMed ID: 4515656
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Laursen B; Gormsen J
    Scand J Haematol; 1969; 6(6):402-8. PubMed ID: 5374117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.